AU2003233310A1 - Agent and method for transporting biologically active molecules in cells - Google Patents

Agent and method for transporting biologically active molecules in cells

Info

Publication number
AU2003233310A1
AU2003233310A1 AU2003233310A AU2003233310A AU2003233310A1 AU 2003233310 A1 AU2003233310 A1 AU 2003233310A1 AU 2003233310 A AU2003233310 A AU 2003233310A AU 2003233310 A AU2003233310 A AU 2003233310A AU 2003233310 A1 AU2003233310 A1 AU 2003233310A1
Authority
AU
Australia
Prior art keywords
cells
agent
biologically active
active molecules
transporting biologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003233310A
Inventor
Laurent Chaloin
Tobias Restle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU2003233310A1 publication Critical patent/AU2003233310A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3513—Protein; Peptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU2003233310A 2002-05-08 2003-05-08 Agent and method for transporting biologically active molecules in cells Abandoned AU2003233310A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10220648 2002-05-08
DE10220648.1 2002-05-08
PCT/EP2003/004833 WO2003094973A1 (en) 2002-05-08 2003-05-08 Agent and method for transporting biologically active molecules in cells

Publications (1)

Publication Number Publication Date
AU2003233310A1 true AU2003233310A1 (en) 2003-11-11

Family

ID=29413722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003233310A Abandoned AU2003233310A1 (en) 2002-05-08 2003-05-08 Agent and method for transporting biologically active molecules in cells

Country Status (2)

Country Link
AU (1) AU2003233310A1 (en)
WO (1) WO2003094973A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005098038A2 (en) * 2004-03-05 2005-10-20 Research Foundation Of State University Of New York Use of rna polymerase as an information-dependent molecular motor
KR101418367B1 (en) 2005-05-04 2014-07-25 녹손 파르마 아게 HMGA-Binding Nucleic acids
WO2011046983A2 (en) 2009-10-12 2011-04-21 Smith Holdings, Llc Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6460734B1 (en) * 1990-06-06 2002-10-08 Lancer Partnership Dispensing apparatus including a pump package system
EP1305333A4 (en) * 2000-07-31 2006-04-12 Active Motif Peptide-mediated delivery of molecules into cells
US7790171B1 (en) * 2000-08-25 2010-09-07 Centre National De La Recherche Scientifique (C.N.R.S.) Antiviral peptides obtained from the tryptophan-rich hydrophobic cluster of the HIV-1 reverse transcriptase

Also Published As

Publication number Publication date
WO2003094973A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
AU2003265388A1 (en) Method and apparatus for operating mobile nodes in multiple states
AU2003269041A1 (en) Method and device for screening molecules in cells
AU2003297552A1 (en) Enzyme immobilization for use in biofuel cells and sensors
AU2003259089A1 (en) Methods and apparatus for operating mobile nodes in multiple states
AU2003223386A1 (en) Low-power high-performance memory cell and related methods
AU2003230985A1 (en) Method and composition for preventing pain in sickle cell patients
AU2002231058A1 (en) Biologically active agent delivery apparatus and method
AU2003268033A1 (en) Systems and methods for cell preservation
EP1577384A4 (en) Plant with reduced protein content in seed, method of constructing the same and method of using the same
IL176116A0 (en) Cryogranulation and storage method for active pharmaceutical agents
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU2003278770A1 (en) Electrochemical cells and systems
GB2393293B (en) System and method for operating in endian independent mode
AU2003301186A1 (en) Method and apparatus for following cells
AU2002254942A1 (en) Paracetamol solutions which are stable in storage and ready for infusion
AU2001293140A1 (en) Apparatus and method for maintaining compression of the active area in an electrochemical cell
EP1560948A4 (en) Electrolysis process and cell for use in same
AU2563001A (en) Power transistor module, power amplifier and method in the fabrication thereof
AU2002237739A1 (en) Method of using web-enabling technology in support of workflow policies and processes
AU2003249390A1 (en) Microparticles bearing cells and active substances
AU2001293139A1 (en) Method and apparatus for maintaining compression of the active area in an electrochemical cell
AU2003207503A1 (en) Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
AU2003277036A1 (en) Method and device for limiting crossover in fuel cell systems
AU2003233310A1 (en) Agent and method for transporting biologically active molecules in cells
AU2001293135A1 (en) Apparatus and method for maintaining compression of the active area in an electrochemical cell

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 547 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME MAX-PLANCK-GESELLSCHAFT ZUR FERDERUNG DER WISSENSCHAFTEN E.V., APPLICATION NO. 2003233310, UNDER INID(43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003